Science:登革热免疫力可能会对寨卡病毒蔓延起缓冲作用

2019-02-24 佚名 生物通

研究小组开发了一种独特的检测方法以测量免疫球蛋白G3。

研究小组开发了一种独特的检测方法以测量免疫球蛋白G3。

2015年,巴西东北部寨卡疫情震荡全球,巴西城市萨尔瓦多贫民窟的居民约73%受到感染。然而,在这一高感染人群中,那些对登革热(一种与寨卡基因相似的病毒)有免疫力的人感染寨卡病毒的风险降低。佛罗里达大学流行病学专家Derek Cummings是研究登革热抗体与寨卡抵抗之间关系的资深研究员,他们最近在2月8日的《Science》杂志上提供了暴露在寨卡下的登革热感染者究竟是如何提供额外免疫力的新见解。“这项研究首次证明,对登革热的免疫可以保护人类免受齐卡病毒感染,”新兴病原体研究所(Emerging Pathogens Institute)生物学教授Cummings说。

由巴西卫生部牵头,Cummings课题组和来自耶鲁大学公共卫生学院以及加州大学旧金山研究所的科学家们对巴西萨尔瓦多Pau da Lima贫民窟1453名居民进行了长期的健康调查。在2015年巴西东北部疫情爆发期间,此地居民可能接触过寨卡病毒。研究小组检查了642名登革热感染居民子集,并分析了他们感染寨卡病毒的风险。“即使这个群体有一定的保护性免疫,但其也遭受了严重的感染,”Cummings说。“我们估计73%居民感染了寨卡病毒。”

研究小组开发了一种独特的检测方法以测量免疫球蛋白G3,它对寨卡的一种关键蛋白有反应。尽管整个研究区域不到四分之一平方公里,但发病率(73%)很高,研究人员惊讶的是,在如此短距离内,寨卡病毒的感染风险竟然存在很大差异,感染率可能取决于环境因素——如蚊子繁殖地,这部分的风险影响从29%到83%高低不等。

642份样本中,86%的样本对登革热呈阳性,对于那些先前对登革热有免疫力的人来说,抗体滴度每增加一倍,寨卡感染风险就降低9%。

“虽然只有少数易感人群没有受到寨卡病毒感染,但寨卡流行已经在美洲造成了总体的高免疫率,对未来几年的疫情爆发设置了一道屏障,”Cummings说。

原始出处:Rodriguez-Barraquer I, Costa F, Nascimento EJM, et al. Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region. Science. 2019 Feb 8;363(6427):607-610.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1307708, encodeId=49c4130e708e7, content=<a href='/topic/show?id=85d2289e188' target=_blank style='color:#2F92EE;'>#免疫力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28971, encryptionId=85d2289e188, topicName=免疫力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3547346, createdName=dongjia2010, createdTime=Tue Feb 26 04:46:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360109, encodeId=bae81360109af, content=<a href='/topic/show?id=6783466083f' target=_blank style='color:#2F92EE;'>#寨卡病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46608, encryptionId=6783466083f, topicName=寨卡病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Tue Feb 26 04:46:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375922, encodeId=c19013e5922f9, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Tue Feb 26 04:46:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512960, encodeId=735b1512960d5, content=<a href='/topic/show?id=f0364660360' target=_blank style='color:#2F92EE;'>#寨卡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46603, encryptionId=f0364660360, topicName=寨卡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d79610514526, createdName=12498710m14暂无昵称, createdTime=Tue Feb 26 04:46:00 CST 2019, time=2019-02-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1307708, encodeId=49c4130e708e7, content=<a href='/topic/show?id=85d2289e188' target=_blank style='color:#2F92EE;'>#免疫力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28971, encryptionId=85d2289e188, topicName=免疫力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3547346, createdName=dongjia2010, createdTime=Tue Feb 26 04:46:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360109, encodeId=bae81360109af, content=<a href='/topic/show?id=6783466083f' target=_blank style='color:#2F92EE;'>#寨卡病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46608, encryptionId=6783466083f, topicName=寨卡病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Tue Feb 26 04:46:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375922, encodeId=c19013e5922f9, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Tue Feb 26 04:46:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512960, encodeId=735b1512960d5, content=<a href='/topic/show?id=f0364660360' target=_blank style='color:#2F92EE;'>#寨卡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46603, encryptionId=f0364660360, topicName=寨卡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d79610514526, createdName=12498710m14暂无昵称, createdTime=Tue Feb 26 04:46:00 CST 2019, time=2019-02-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1307708, encodeId=49c4130e708e7, content=<a href='/topic/show?id=85d2289e188' target=_blank style='color:#2F92EE;'>#免疫力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28971, encryptionId=85d2289e188, topicName=免疫力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3547346, createdName=dongjia2010, createdTime=Tue Feb 26 04:46:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360109, encodeId=bae81360109af, content=<a href='/topic/show?id=6783466083f' target=_blank style='color:#2F92EE;'>#寨卡病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46608, encryptionId=6783466083f, topicName=寨卡病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Tue Feb 26 04:46:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375922, encodeId=c19013e5922f9, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Tue Feb 26 04:46:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512960, encodeId=735b1512960d5, content=<a href='/topic/show?id=f0364660360' target=_blank style='color:#2F92EE;'>#寨卡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46603, encryptionId=f0364660360, topicName=寨卡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d79610514526, createdName=12498710m14暂无昵称, createdTime=Tue Feb 26 04:46:00 CST 2019, time=2019-02-26, status=1, ipAttribution=)]
    2019-02-26 jichang
  4. [GetPortalCommentsPageByObjectIdResponse(id=1307708, encodeId=49c4130e708e7, content=<a href='/topic/show?id=85d2289e188' target=_blank style='color:#2F92EE;'>#免疫力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28971, encryptionId=85d2289e188, topicName=免疫力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3547346, createdName=dongjia2010, createdTime=Tue Feb 26 04:46:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1360109, encodeId=bae81360109af, content=<a href='/topic/show?id=6783466083f' target=_blank style='color:#2F92EE;'>#寨卡病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46608, encryptionId=6783466083f, topicName=寨卡病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Tue Feb 26 04:46:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375922, encodeId=c19013e5922f9, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Tue Feb 26 04:46:00 CST 2019, time=2019-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1512960, encodeId=735b1512960d5, content=<a href='/topic/show?id=f0364660360' target=_blank style='color:#2F92EE;'>#寨卡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46603, encryptionId=f0364660360, topicName=寨卡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d79610514526, createdName=12498710m14暂无昵称, createdTime=Tue Feb 26 04:46:00 CST 2019, time=2019-02-26, status=1, ipAttribution=)]

相关资讯

Virus Res:奎宁可作为抗登革热病毒感染治疗药物

近日,来自泰国的科学家发现,奎宁具有治疗登革热病毒感染的作用,该研究结果目前已发表至《Virus Research》杂志

疾控部门提醒:长假出游谨防登革热

国庆长假将至,很多家庭和个人将前往南方地区旅行。为此,疾控部门发布健康提醒,国庆期间外出要做好防蚊措施,谨防登革热蚊媒传染病。

探案:旅游归来现高热,青霉素用后发皮疹——真相是啥?

女性,33岁,浙江人,职员。主诉:发热7天

J Virol:中国和美国的科学家联合开发出制备登革热候选疫苗毒株的方法

目前,该病毒还没有有效的商品化疫苗来预防。近日,来自武汉病毒研究所的科学家和美国的科学家合作,开发出了一种新的制备登革热病毒疫苗毒株的方法

中国登革热临床诊断和治疗指南

登革热是由登革病毒( dengue virus,DENV)引起的急性传染病,是全球传播最广泛的蚊媒传染病之一。近年来,我国登革热疫情逐渐由东南沿海地区向全国各地蔓延。我国登革热的临床及实验室特征与国外地方性流行地区报道有较大差异,绝大多数患者为成人,重症病例多为伴有基础疾病的老年人,临床医师对登革热早期诊断及重症救治经验不足。为规范登革热的诊断、治疗和预防,中华医学会感染病学分会、中华医学会热带病

PNAS:人体中循环的登革1型病毒具有高度传染性

最近的研究表明,在细胞培养测定中中和DENV的疫苗诱导的抗体不足以保护人免受DENV感染。